Award
Delivery Order #SPE2DR26FF4FB
Delivery Order for Novolog FlexPen by AmerisourceBergen under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$1,072.32
Ceiling
$1,072.32
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26FF4FB
NAICS
424210
This award represents a delivery order contract for the procurement of Novolog 100 Unit/mL FlexPen 3mL insulin units, issued under a larger indefinite delivery vehicle (IDV) contract focused on pharmaceutical supplies. The recipient, AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, is tasked with supplying this critical diabetes medication to support healthcare providers. The contract underscores the agency's ongoing commitment to ensuring timely access to essential pharmaceuticals, vital for public health management. The scope covers the delivery of specified insulin units within a concise performance period, reflecting a targeted fulfillment of medical product needs. This order is a continuation of the substantial multi-year IDV contract with AmerisourceBergen, which strategically supports the agency's pharmaceutical distribution infrastructure. Awarded on a competitive basis as part of the broader IDV vehicle, this action highlights the efficiency and reliability of AmerisourceBergen in fulfilling pharmaceutical procurement requirements. The performance timeframe is a short-term, precise delivery window, ensuring rapid availability of the product at the specified location in Conshohocken, Pennsylvania.
Description
4570802932!NOVOLOG 100 UNIT/ML FLEXPEN 3ML